Sign In
Buy BSX
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Boston Scientific Unveils “Practice-Transforming” Trial Data for PE and AF at ACC Conference Call
03:06am, Monday, 30'th Mar 2026
Boston Scientific (NYSE: BSX) executives highlighted new data from two randomized clinical trials during an American College of Cardiology conference call, describing the results as potentially "pract
New York, New York--(Newsfile Corp. - March 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between
New class action for Boston Scientific (BSX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their Options If you purchased o
Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo Transcript
Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial fibrilla
Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. antico
What Moved Markets This Week
06:44am, Saturday, 28'th Mar 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
New York, New York--(Newsfile Corp. - March 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:21pm, Friday, 27'th Mar 2026
LOS ANGELES, March 27, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Boston Sci
NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE: BSX).
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their Options If you purchased o
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
05:58pm, Thursday, 26'th Mar 2026
NEW YORK, March 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025
New York, New York--(Newsfile Corp. - March 26, 2026) - Bernstein Liebhard LLP announces that a shareholder has filed a
NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX).
